A. Ouédraogo

发表

Risk factors associated with house entry of malaria vectors in an area of Burkina Faso with high, persistent malaria transmission and high insecticide resistance

Anne L. Wilson, S. Lindsay, A. Wilson, 2021, Malaria journal.

Maintaining Plasmodium falciparum gametocyte infectivity during blood collection and transport for mosquito feeding assays in the field

T. Bousema, C. Drakeley, U. d’Alessandro, 2021, Malaria journal.

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

K. Neuzil, Shrimati Datta, S. Sirima, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Malaria Journal BioMed Central

S. Sirima, W. Taylor, A. Gansané, 2009 .

Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether–Lumefantrine: Impact on the Prevalence of Anemia

K. Hamed, A. Tiono, A. Ouédraogo, 2013, Infectious Diseases and Therapy.

Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso

S. Cousens, S. Sirima, O. Leroy, 2009, Parasite immunology.

Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods

S. Sirima, A. Rehman, P. Milligan, 2014, PloS one.

Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial

T. Bousema, J. Gerardin, C. Drakeley, 2019, BMJ Open.

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

Q. Bassat, S. Issifou, P. Kremsner, 2017, BMC Medicine.

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso

S. Sirima, I. Nébié, I. Soulama, 2012, Malaria Journal.

Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey

Anne L. Wilson, S. Lindsay, A. Wilson, 2021, Malaria Journal.

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso

S. Sirima, K. Hamed, I. Soulama, 2014, Malaria Journal.

Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.

S. Sirima, M. Parise, R. Newman, 2006, The American journal of tropical medicine and hygiene.

Abnormalities of Hemoglobin and Glucose-6-Phosphate-Dehydrogenase Deficiency in Children with Uncomplicated Malaria and Living in Banfora and Saponé, Two Different Malaria Setting of Burkina Faso

S. Sirima, I. Nébié, I. Soulama, 2019, International Journal of TROPICAL DISEASE & Health.

A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper

K. Neuzil, S. Sirima, Yuanyuan Liang, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial

S. Cousens, D. Chandramohan, S. Sirima, 2011, PLoS medicine.

The effects of a pre‐season treatment with effective antimalarials on subsequent malaria morbidity in under five‐year‐old children living in high and seasonal malaria transmission area of Burkina Faso

S. Sirima, I. Nébié, A. Tiono, 2010, Tropical medicine & international health : TM & IH.

Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention

Anne L. Wilson, S. Lindsay, H. Ranson, 2022, Scientific reports.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial

T. Bousema, C. Drakeley, S. Sirima, 2016, BMC Medicine.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials

T. Bousema, M. Niemi, C. Drakeley, 2018, PLoS ONE.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

A cohort study to identify risk factors for malaria in Burkinabe children: implications for other high burden high impact countries

Anne L. Wilson, S. Lindsay, H. Ranson, 2020 .

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial

O. Doumbo, J. Kimani, Kirana M Bhatt, 2012, Malaria Journal.

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected

T. Bousema, C. Drakeley, K. Dechering, 2019 .

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso

T. Bousema, C. Drakeley, K. Dechering, 2018, Wellcome open research.

Increased gametocyte production and mosquito infectivity in chronic versus incident Plasmodium falciparum infections

T. Bousema, C. Drakeley, S. Sirima, 2020 .

Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding☆

D. Wirth, T. Bousema, C. Drakeley, 2018, International journal for parasitology.

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria

T. Clark, T. Bousema, C. Drakeley, 2019, Malaria Journal.

PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.

B. Gamain, E. Tartour, S. Sirima, 2020, The Lancet. Infectious diseases.

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age

S. Sirima, J. Sadoff, M. Pau, 2013, PloS one.

Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.

S. Sirima, D. Borys, N. François, 2017, The Pediatric infectious disease journal.

Immunogenicity and Safety Of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children with Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.

S. Sirima, D. Borys, N. François, 2017, The Pediatric infectious disease journal.

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children

P. Bejon, S. Sirima, A. Lawrie, 2018, PloS one.

A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria

G. E. Potter, S. Hoffman, S. Sirima, 2022, Science Translational Medicine.

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.

Teun Bousema, Hannah C. Slater, Kevin C Kobylinski, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso

S. Sirima, I. Soulama, Edith C. Bougouma, 2015, Journal of parasitology research.

Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections

T. Bousema, C. Drakeley, S. Sirima, 2021, Nature Communications.

Ef fi cacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment : A Double-Blind , Randomized , Clinical Trial

T. Bousema, Kevin C. Kobylinski, C. Drakeley, 2015 .

Seasonal Depiction of Malariometric Indices in Children under Five Years in a Sudanese Semi-urban Area of Burkina Faso

S. Sirima, M. Vaillant, A. Tiono, 2019, International Journal of TROPICAL DISEASE & Health.

Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa

R. Chilengi, S. Sirima, P. Milligan, 2007, Infection and Immunity.

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso

Bernhards Ogutu, B. Ogutu, S. Sirima, 2013, Malaria Journal.

Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?

D. Cavanagh, S. Sirima, M. Theisen, 2015, Acta tropica.

Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso

S. Sirima, M. Torcia, D. Modiano, 2012, BMC Research Notes.

An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal

A. Sié, B. Faye, C. Sokhna, 2017, Malaria Journal.

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso

S. Sirima, I. Soulama, Edith C. Bougouma, 2012, Malaria Journal.

Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention

Anne L. Wilson, S. Lindsay, H. Ranson, 2021, Scientific Reports.

A cohort study to identify risk factors for Plasmodium falciparum infection in Burkinabe children: implications for other high burden high impact countries

Anne L. Wilson, S. Lindsay, H. Ranson, 2020, Malaria journal.

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso

S. Sirima, A. Gansané, I. Soulama, 2013, PloS one.

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial

O. Doumbo, J. Kimani, Kirana M Bhatt, 2012, Malaria Journal.

Relationship between human genetic factors and Plasmodium falciparum genetic diversity of msp1, msp2 and glurp in a malaria endemic area of Burkina Faso

I. Soulama, Y. Traoré, A. Diarra, 2019, Biomedical Genetics and Genomics.

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children

T. Horii, S. Cousens, S. Sirima, 2022, Frontiers in Immunology.

Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial

Steve W Lindsay, Brian Faragher, S. Lindsay, 2018, The Lancet.

Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial

S. Cousens, D. Chandramohan, B. Greenwood, 2011, PloS one.

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial

K. Neuzil, Shrimati Datta, S. Sirima, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso

S. Sirima, Edith C. Bougouma, A. Tiono, 2011, Journal of tropical medicine.

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens

S. Sirima, Edith C. Bougouma, A. Tiono, 2009, Malaria Journal.

FcγRIIa Polymorphism and Anti‐Malaria‐Specific IgG and IgG Subclass Responses in Populations Differing in Susceptibility to Malaria in Burkina Faso

D. Cavanagh, S. Sirima, M. Theisen, 2012, Scandinavian journal of immunology.

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso

D. Cavanagh, S. Sirima, A. Tiono, 2017, BMC Research Notes.

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso

S. Sirima, A. Gansané, I. Soulama, 2012, Parasites & Vectors.

Population pharmacokinetics of artesunate and amodiaquine in African children

J. Simpson, S. Sirima, K. Stepniewska, 2009, Malaria Journal.

Health Providers’ Perceptions of Clinical Trials: Lessons from Ghana, Kenya and Burkina Faso

S. Owusu-Agyei, D. Chandramohan, S. Sirima, 2015, PloS one.

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)

H. Tinto, B. Ogutu, A. Tshefu, 2015, Malaria Journal.

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

H. Tinto, B. Ogutu, D. Leroy, 2021, Malaria Journal.

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso

S. Sirima, M. Theisen, D. Dodoo, 2012, Malaria Journal.

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

K. Neuzil, Shrimati Datta, S. Sirima, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children

T. Horii, S. Sirima, N. Arisue, 2023, Frontiers in Immunology.

[Chemioprophylaxis of malaria by weekly distributions of chloroquine or a chloroquine-primaquine-pyrimethamine combination].

A. Escudie, A. Ouédraogo, J. Schneider, 1962, Bulletin de la Societe de pathologie exotique et de ses filiales.

Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

S. Sirima, K. Ewer, R. Morter, 2022, Frontiers in Immunology.

Risk Factors for Plasmodium Falciparum Infection in Pregnant Women in Burkina Faso: A Community-Based Malaria Cross-Sectional Survey

Anne L. Wilson, S. Lindsay, T. Bousema, 2021 .

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children

S. Cousens, S. Sirima, Y. Kaboré, 2009, PloS one.

Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa

S. Cousens, S. Sirima, O. Leroy, 2007 .